The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis

被引:1
|
作者
Kadota, Jun-ichi
Mizunoe, Syunji
Mukae, Hiroshi
Mito, Katsuhiko
Kishi, Kenji
Tokimatsu, Issei
Nagai, Hiroyuki
Tomono, Kazunori
Kohno, Shigeru
Nasua, Masaru
机构
[1] Oita Univ, Fac Med, Dept Infect Dis, Div Pathogenesis & Dis Control, Oita 8795593, Japan
[2] Nagasaki Univ, Sch Med, Dept Internal Med, Nagasaki 852, Japan
关键词
apoptosis; Bax; Bcl-2; caspase-3; lung tissue; diffuse panbronchiolitis;
D O I
10.1016/j.rmed.2006.02.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diffuse panbronchiolitis (DPB) is a distinctive form of small airway disease, which is characterized by chronic inflammation with lymphocyte infiltration around bronchioles. The aim of this study was to evaluate the importance of factors related to apoptosis in peribronchiolar lymphocytes of DPB. We employed immunohistochemical methods for the localization of Bax (a promoter of apoptosis), Bcl-2 (an inhibitor of apoptosis), and caspase-3 (a key executioner molecule of apoptosis) in lung tissues of five patients with DPB. In all patients, immunostaining for Bax was almost completely absent in accumulated lymphocytes around the bronchioles and in lymphocytes of the parafollicular area that correspond to a zone populated by T cells. In contrast to the reaction for Bax, Bcl-2 immunoreactivity was uniformly strong in all of the patients. The pattern of staining for caspase-3 was similar to that for Bax in all of the patients. In normal lung tissue, a few lymphocytes showed negative immunostaining for BcL-2 and a positive reaction for caspase-3. Our results suggest that Bcl-2 protein may provide T-lymphocyte survival and hypercellularity in the bronchioles, thereby contributing to the progression of DPB. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2029 / 2036
页数:8
相关论文
共 50 条
  • [1] The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis
    Sharief, MK
    Douglas, M
    Noori, M
    Semra, YK
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 125 (1-2) : 155 - 162
  • [2] EXPRESSION OF PRO- AND ANTI-APOPTOTIC Bcl-2 RELATED PROTEINS IN LEYDIG CELLS OF AGING RAT TESTIS
    Koeva, Yvetta
    Bakalska, Mariana
    Atanassova, Nina
    Nikolov, Boicho
    Delchev, Stephan
    Davidoff, Michail
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2009, 62 (10): : 1327 - 1332
  • [3] Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma
    Singh, Lata
    Pushker, Neelam
    Saini, Neeru
    Sen, Seema
    Sharma, Anjana
    Bakhshi, Sameer
    Chawla, Bhavna
    Kashyap, Seema
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 (03): : 259 - 267
  • [4] Anti-Apoptotic and Pro-Apoptotic Bcl-2 Family Proteins in Peri-Implant Diseases
    Yilmaz, Dogukan
    Gursoy, Mervi
    Gursoy, Ulvi Kahraman
    CLINICAL ORAL IMPLANTS RESEARCH, 2023, 34 (06) : 582 - 590
  • [5] Pro- and anti-apoptotic members of the Bcl-2 family in skeletal muscle: A distinct role for Bcl-2 in later stages of myogenesis
    Dominov, JA
    Houlihan-Kamamoto, CA
    Swap, CJ
    Miller, JB
    DEVELOPMENTAL DYNAMICS, 2001, 220 (01) : 18 - 26
  • [6] The cellular concentration of Bcl-2 determines its pro- or anti-apoptotic effect
    Hanson, C. Jane
    Bootman, Martin D.
    Distelhorst, Clark W.
    Maraldi, Tullia
    Roderick, H. Llewelyn
    CELL CALCIUM, 2008, 44 (03) : 243 - 258
  • [7] Designing Peptide Inhibitors of Anti-Apoptotic Bcl-2 Family Proteins
    Keating, Amy E.
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 21A - 22A
  • [8] Exploring the conformational space of anti-apoptotic proteins of the Bcl-2 family
    Caro-Gomez, Luis
    PROTEIN SCIENCE, 2017, 26 : 47 - 48
  • [9] Rise of the Selective Inhibitors of Anti-Apoptotic Bcl-2 Family Proteins
    Han, Li
    Wang, Renxiao
    CHEMMEDCHEM, 2013, 8 (09) : 1437 - 1440
  • [10] Targeting anti-apoptotic BCL-2 family proteins for cancer treatment
    Zhang, Xuan
    Liu, Xingui
    Zhou, Daohong
    Zheng, Guangrong
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (07) : 563 - 565